However, unlike FXS patients, none of these mice models have reliably shown hypermethylation of the inserted CGG repeats, indicating that the reduced expression of FMRP occurs through a different mechanism in mouse and humans (Brouwer et al., 2008; Entezam et al., 2007). This evidence concerns the gene FMR1 and fragile X syndrome.